Utilizing Actionable Classifications in TNBC
BY ADITYA BARDIA, MD, MPH
Oncology Nurses Provide Patients an Avenue to Supportive Care
BY DIANA MARTINS-WELCH, MD
Referring Patients to the Right Support Group
BY SALLY WERNER, RN, BSN, MSHA
Challenges In AML Treatment
BY PINKAL DESAI, MD
Searching for Prognostic Markers in Patients with Osteosarcoma
BY ELHAM NASRI, MD
Expert Discusses Genetic Predisposition to Prostate Cancer in Racially Diverse Patient Populations
BY CURTIS A. PETTAWAY, MD
Expert Identifies Potential Biomarkers for Hairy Cell Leukemia
BY JAMES BLACHLY, MD
Measurable Residual Disease's Role in the Relapse Setting
BY FRAHAD RAVANDI-KASHANI, MD
Addressing the Unmet Needs of Patients with Hairy Cell Leukemia
BY KERRY ROGERS, MD
Expert Discusses the Safety of Vemurafenib
BY AGNIESZKA JANUS, MD, PHD
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.